http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11893192

Outgoing Links

Predicate Object
contentType Clinical Trial|Comparative Study|Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, N.I.H., Extramural|Research Support, U.S. Gov't, P.H.S.
endingPage 1335
issn 0026-0495
issueIdentifier 10
pageRange 1331-1335
publicationName Metabolism: clinical and experimental
startingPage 1331
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9734d3fe23dc2a28533ae979d76d12f8
bibliographicCitation Fonseca VA, Kelley DE, Cefalu W, Baron MA, Purkayastha D, Nestler JE, Hsia S, Gerich JE. Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus. Metabolism. 2004 Oct;53(10):1331–5. doi: 10.1016/j.metabol.2004.05.009. PMID: 15375790.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06cb579ec984ddcda7286f9883e3dce3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57d1521e624cbe958836810489294293
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dfceaa054cdef58fb57081c9d0c363d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4cec8a5100650b7246872e5acad257a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9405edc852ab6b0c96dd17a1c4ca923a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_caa5588109bbcfd832b500c70116ea7a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_49c8cd97b67a37e9667b3a736547708e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76ff0810c4d2d020f509dff5258c15be
date 200410
identifier https://doi.org/10.1016/j.metabol.2004.05.009
https://pubmed.ncbi.nlm.nih.gov/15375790
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5782
https://portal.issn.org/resource/ISSN/0026-0495
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus
discusses http://id.nlm.nih.gov/mesh/M0011417
http://id.nlm.nih.gov/mesh/M0010903
http://id.nlm.nih.gov/mesh/M0353981
http://id.nlm.nih.gov/mesh/M0016544
http://id.nlm.nih.gov/mesh/M0009265
http://id.nlm.nih.gov/mesh/M0002696
http://id.nlm.nih.gov/mesh/M0005469
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D007004Q000627
http://id.nlm.nih.gov/mesh/D005905Q000627
http://id.nlm.nih.gov/mesh/D003510Q000627
http://id.nlm.nih.gov/mesh/D003924Q000188
http://id.nlm.nih.gov/mesh/D010649Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D019540
http://id.nlm.nih.gov/mesh/D003924Q000097
http://id.nlm.nih.gov/mesh/D000077715
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D007004Q000009
http://id.nlm.nih.gov/mesh/D010649Q000009
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005905Q000009
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D007328Q000097
http://id.nlm.nih.gov/mesh/D015309
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D003510Q000009
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D004311
http://id.nlm.nih.gov/mesh/D010649Q000031
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D001786Q000378
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129928295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136164596

Total number of triples: 71.